Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
about
Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung diseaseThe molecular basis of asbestos induced lung injuryPulmonary diseases other than asthma as potential targets for antileukotriene therapy.Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.Contribution of reactive oxygen and nitrogen species to particulate-induced lung injury.Minerals, fibrosis, and the lung.Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosisEicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?Relationship of inflammatory cell cytokines to disease severity in individuals with occupational inorganic dust exposure.Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosisCellular and molecular basis of the asbestos-related diseases.Opposing roles of leukotrienes and prostaglandins in fibrotic lung disease.Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosisNeutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure.Protection from pulmonary fibrosis in leukotriene-deficient mice.Mechanical stress activates xanthine oxidoreductase through MAP kinase-dependent pathways.
P2860
Q26341878-3A333B25-9DAF-40BC-9D82-2E6180E16204Q28394122-8107D25F-0E93-4392-9C69-CEB8DF3A8AF3Q33705523-47BF1E70-0D47-42F7-B60E-342A9A3902E8Q34842613-631DB042-2171-40AA-9689-98BD08D76741Q34941303-DCA7474D-46F0-466B-B758-FC84913C0540Q35033910-B1B12093-B765-482B-ACB9-20784C1142D0Q35563094-BAEB3D53-2619-4283-BCBC-540FE3C3A934Q36970702-1C32D0E9-8853-44CE-A556-595490BABFBCQ37157545-59127CB0-7CD0-427B-BC34-235FBB589A8BQ37354132-0D1B31CF-E96E-4482-BC02-66C996960615Q37631762-CD5D77A6-BC1B-444D-AB78-ADBA27F5C51CQ37754750-22641802-3BA0-42E2-99F4-1487E32D8906Q41984856-FA4A886D-93CB-437D-AAD4-6833D4D69C34Q42060725-CDE00B10-F864-4582-870D-1A422E3337E2Q42510176-61B37D45-EBF7-4BD6-A89D-9BD30B4D9747Q43854271-605913AC-CB0A-473B-B2DF-7C747A22471AQ50479892-D20DF500-007E-4362-A1A1-DFA087BE45E3
P2860
Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@en
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@nl
type
label
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@en
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@nl
prefLabel
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@en
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@nl
P2093
P2860
P356
P1476
Alveolar macrophages from pati ...... ased levels of leukotriene B4.
@en
P2093
Callahan KS
Griffith DE
P2860
P304
P356
10.1164/AJRCCM/139.6.1494
P577
1989-06-01T00:00:00Z